InsidersTradesSigma
Discover the detailed record of transactions filed by MALKIEL BURTON G, Director. Officer active across 1 company, notably Theravance Biopharma, Inc.. In total, 1 reports have been published. Activity tracked since 26 April 2022. The latest transaction was disclosed on 26 April 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Burton G. Malkiel is a Board Member at Theravance Biopharma, Inc. As a board member, he plays a key role in overseeing the company's activities and making strategic decisions. His experience in the biopharmaceutical field is an asset in guiding the company towards innovation.